Nous utilisons des cookies et des outils d'analyse (Google Analytics, Google Tag Manager) pour améliorer votre expérience. En acceptant, vous consentez à l'utilisation de ces technologies. Vous pouvez modifier vos préférences à tout moment.

blog.fallback_notice_title
blog.fallback_notice_body
blog.key_takeaways
Botox is one of the most common aesthetic treatments, but it should never be approached as if every patient carries the same risk profile. Pregnancy, breastfeeding, diabetes, blood thinners, autoimmune disease, smoking, and heavy sun exposure all change how I think about safety.
The key principle is simple: when evidence is limited or recovery may be impaired, caution is better than convenience. A short delay is often the safer medical decision.
In pregnancy, cosmetic Botox is generally considered inappropriate and should be deferred. Controlled human data are limited, and that uncertainty matters more than the desire for a temporary aesthetic result.
Because fetal safety has not been clearly established, I advise patients to avoid elective toxin treatment during pregnancy and to inform their physician immediately if they become pregnant while planning care.
Botulinum toxin is a large protein, so meaningful transfer into breast milk is thought to be unlikely. Even so, strong clinical evidence in breastfeeding patients is lacking, which is why most physicians prefer postponement.
If the concern is cosmetic rather than medical, delaying Botox until breastfeeding has ended is usually the clearest and most conservative recommendation.
Dr. Gemici: When the benefit is elective and the data are incomplete, I do not try to be aggressive. In pregnancy and breastfeeding, a delayed injection is usually the wiser plan.
Patients with well-controlled diabetes can often receive Botox safely, but I pay closer attention to healing quality, infection risk, blood sugar control, and general medical stability. Poorly controlled diabetes deserves more caution and sometimes postponement.
Smoking and intense UV exposure do not create the same type of contraindication as pregnancy, but they may worsen skin quality, prolong irritation, and work against aesthetic goals. Strong aftercare and realistic counseling become more important in these patients.
Patients on anticoagulants or antiplatelet drugs may still be treated, but bruising risk is higher and technique must be gentler. Medication changes should never be made casually without the prescribing physician.
Certain neuromuscular disorders are true contraindications, while many autoimmune conditions require individualized review rather than automatic rejection. After recent vaccination, it is often sensible to leave a short interval before elective Botox so that post-vaccine reactions are not confused with treatment effects.
For cosmetic purposes, it is generally postponed. The main issue is limited safety data, not proven benefit from proceeding.
Clinically it is usually better to wait until breastfeeding is over, because solid evidence in lactating patients is still limited.
Not always. Well-controlled diabetes may still allow treatment, but the decision should account for healing, infection risk, and overall medical status.

Trusted & Professional
Dr Hamza Gemici est un médecin en esthétique médicale basé à Ataşehir, Istanbul. Sa pratique repose sur un anti-âge naturel et une harmonisation subtile du visage à l aide de toxine botulique, fillers dermiques, rajeunissement péri-oculaire et traitements de qualité cutanée. Toutes les procédures sont réalisées avec des produits approuvés FDA et sous protocole médical.